RKTONasdaqPharmaceutical PreparationsFiscal year ends December 31
Rocket One Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.50−0.01 (-1.97%)
Close on Oct 19, 2026
- Market cap
- $10.21M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
6.5%
2M of 25M shares
Institutional holders
21
6 new, 4 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of RKTO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 683,291 | 2.74% | $683.29K | +553,600 | 0.00% |
| Jane Street Group, LLC | 219,316 | 0.88% | $219.32K | New | 0.00% |
| UBS Group AG | 211,304 | 0.85% | $211.30K | +53,327 | 0.00% |
| Geode Capital Management, LLC | 195,982 | 0.79% | $195.98K | −18,262 | 0.00% |
| Vanguard Fiduciary Trust Co | 84,318 | 0.34% | $84.32K | – | 0.00% |
| State Street Corp | 63,939 | 0.26% | $63.94K | – | 0.00% |
| LPL Financial LLC | 41,029 | 0.16% | $41.03K | New | 0.00% |
| Northern Trust Corp | 38,724 | 0.16% | $38.72K | −3,330 | 0.00% |
| Susquehanna International Group, Llp | 25,966 | 0.10% | $25.97K | New | 0.00% |
| Lido Advisors, LLC | 19,500 | 0.08% | $19.50K | −19,500 | 0.00% |
| Morgan Stanley | 10,006 | 0.04% | $10.01K | – | 0.00% |
| Charles Schwab Trust Co | 10,000 | 0.04% | $10.00K | New | 0.00% |
| SBI Securities Co., Ltd. | 4,517 | 0.02% | $4.52K | +4,506 | 0.00% |
| Farther Finance Advisors, LLC | 4,237 | 0.02% | $4.24K | New | 0.00% |
| Osaic Holdings, Inc. | 2,701 | 0.01% | $2.70K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 2,005 | 0.01% | $2.01K | −5,350 | 0.00% |
| Federation des caisses Desjardins du Quebec | 350 | 0.00% | $343 | – | 0.00% |
| Royal Bank of Canada | 240 | 0.00% | $0 | −630 | 0.00% |
| Jones Financial Companies Lllp | 100 | 0.00% | $95 | −400 | 0.00% |
| McGuire Capital Advisors Inc | 50 | 0.00% | $50 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 21 | 2M | 6.5% | 6 / 3 | 6 / 4 | 1M | 0M |
| Q1 2026 | 19 | 1M | 3.2% | 4 / 5 | 2 / 7 | 0M | 0M |
| Q4 2025 | 23 | 1M | 4.0% | 6 / 4 | 7 / 8 | 0M | 1M |
| Q3 2025 | 25 | 1M | 5.4% | 12 / 7 | 3 / 2 | 1M | 0M |
| Q2 2025 | 15 | 0M | 1.1% | 2 / 5 | 3 / 4 | 0M | 0M |
| Q1 2025 | 17 | 0M | 1.2% | 5 / 5 | 3 / 3 | 0M | 0M |
| Q4 2024 | 15 | 0M | 1.0% | 5 / 3 | 5 / 2 | 0M | 0M |
| Q3 2024 | 12 | 0M | 1.5% | 3 / 4 | 1 / 2 | 0M | 0M |
| Q2 2024 | 11 | 0M | 1.4% | 1 / 4 | 4 / 0 | 0M | 0M |
| Q1 2024 | 10 | 1M | 2.1% | 2 / 4 | 1 / 3 | 0M | 0M |
| Q4 2023 | 11 | 0M | 0.3% | 3 / 3 | 0 / 2 | 0M | 0M |
| Q3 2023 | 10 | 0M | 0.4% | 2 / 1 | 2 / 2 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of RKTO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 505,300 | 2.03% | $505.30K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 129,691 | 0.52% | $129.69K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 119,035 | 0.48% | $173.79K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 31,711 | 0.13% | $46.30K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 16,979 | 0.07% | $24.79K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 16,076 | 0.06% | $23.47K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robb Knie | CEO and President, Director | 547,387 | 2.20% | May 28, 2026 |
| David Sarnoff | Director | 25,000 | 0.10% | May 28, 2026 |
| Wayne Linsley | Director | 3,333 | 0.01% | May 28, 2026 |
| Jeff Pavell | Director | 5,075 | 0.02% | May 28, 2026 |
| Christopher Michael Camarra | Director | – | – | May 28, 2026 |
| Graig Springer | Director | 3,333 | 0.01% | Jan 15, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Robb Knie CEO and President, Director | Aug 28, 2025 | Tax withholding | −310,744 | $1.21 | $376.00K | 547,387 |
| Robb Knie CEO and President, Director | Aug 27, 2025 | Award | +800,000 | – | – | 858,131 |
| Robb Knie CEO and President, Director | Aug 16, 2024 | Buy | +25,000 | $0.67 | $16.75K | 58,131 |
| Jeff Pavell Director | Dec 13, 2022 | Award | +5,075 | – | – | 5,075 |
| Robb Knie CEO and President, Director | Sep 19, 2022 | Buy | +10,000 | $0.39 | $3.90K | 828,259 |
| Robb Knie CEO and President, Director | Sep 16, 2022 | Buy | +10,000 | $0.40 | $4.00K | 818,259 |
| Pharma Inc. AIkido 10% owner | May 26, 2020 | Sale | −400,000 | $1.25 | $500.00K | 1,130,674 |
| Anthony Hayes – | May 26, 2020 | Sale | −0 | – | – | 0 |
| Anthony Hayes 10% owner | May 26, 2020 | Sale | −400,000 | $1.25 | $500.00K | 1,130,674 |
| Robb Knie CEO and President, Director | May 18, 2020 | Other | +4 | – | – | 808,259 |
| Wayne Linsley Director | Apr 15, 2020 | Award | +3,333 | – | – | 3,333 |
| Graig Springer Director | Apr 15, 2020 | Award | +3,333 | – | – | 3,333 |
| Pharma Inc. AIkido 10% owner | Nov 8, 2019 | Other | −9,226 | – | – | 1,636,230 |
| Anthony Hayes Director | Nov 8, 2019 | Other | −9,226 | – | – | 1,600,516 |
| Pharma Inc. AIkido 10% owner | Oct 28, 2019 | Other | −90,258 | – | – | 1,645,456 |
| Anthony Hayes Director | Oct 28, 2019 | Other | −90,258 | – | – | 1,609,742 |
| Anthony Hayes Director | Oct 28, 2019 | Other | +301 | – | – | 105,301 |
| Robb Knie CEO and President, Director | Oct 28, 2019 | Other | +85 | – | – | 808,255 |
| Pharma Inc. AIkido 10% owner | Feb 28, 2019 | Buy | +35,714 | $199998.00 | $7.14B | 1,735,714 |
| Matthew D. Eitner 10% owner | Feb 20, 2019 | Conversion | +15,000 | – | – | 765,000 |
| Kevin Jess Poor 10% owner | Feb 20, 2019 | Conversion | +750,000 | – | – | 750,000 |
| Pharma Inc. AIkido 10% owner | Jun 30, 2017 | Buy | +1,700,000 | $675000.00 | $1.15T | 1,700,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.